Globus Medical logged a -2.09% change during today's afternoon session, and is now trading at a price of $53.37 per share.
Globus Medical shares moved -20.55% over the last 52 weeks, with a high of $81.78 and a low of $52.6. During this time, the stock lagged the S&P 500 index by -13.09%. As of January 2022, the company's 50-day average price is $67.98. Globus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders. The mid-cap Health Care company is based in Audubon, PA.
Operating Margins Consistently Higher Than the 15.02% Industry Average:
|Gross Margins Growth||n/a||-6.02%||3.58%||-1.08%|
|Operating Margins Growth||n/a||-35.53%||27.12%||24.18%|
|Earnings Per Share||$1.55||$1.03||$1.47||$1.9|
|Diluted Shares (MM)||100||99||102||100|
|Free Cash Flow (MM)||$101||$135||$219||$104|
|Capital Expenditures (MM)||$71||$64||$57||$74|
Globus Medical Is Overvalued:
Compared to the Health Care sector's average of 24.45, Globus Medical has a trailing twelve month P/E ratio of 30.32 and, according to its EPS guidance of 2.56, an expected P/E ratio of 20.85. Globus Medical's PEG ratio is 2.17 based on its 14.0% annual average growth rate of historical and projected earnings per share. This suggests that the company's shares are overvalued.
The market is giving Globus Medical a fair value in terms of its book value, since its P/B ratio of 4.211 is consistent with its sector average, which stands at 4.16. The company's shares are currently trading 113.31% above their fair value as expressed by Benjamin Graham's formula:
√(22.5 * 5-year average EPS * book value per share) = √(22.5 * 1.51 * 18.43) = $25.02
Globus Medical Is the Subject of Mixed Market Indicators:
12 analysts are following Globus Medical and have set target prices ranging from $61.0 to $77.0 per share. On average, they have given the company a rating of hold. At the current price of $53.37, GMED is trading -20.54% away from its average analyst target price of $67.17 per share, implying an analyst consensus of strong upside potential for the stock.
The company has an average amount of shares sold short since 5% of the company's shares are tied to short positions. Institutions own 102% of Globus Medical's shares, while the insider ownership rate stands at 1%.